Moderna Receives U.S. FDA Approval for COVID-19 Vaccine mNEXSPIKE - Moderna Investor Relations
mNEXSPIKE becomes Moderna's third FDA-approved product CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE ® (mRNA-1283), a new vaccine against CO…
Comments